Journal of Clinical Epidemiology
Volume 53, Issue 1 , Pages 95-102 , January 2000

Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: Findings from National Health and Nutrition Examination Survey III

  • Earl S Ford

      Affiliations

    • Division of Nutrition and Physical Activity and Division of Adult Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, Atlanta, GA, 30341 USA
    • Corresponding Author InformationCorresponding author. Tel.: 770-488-6015; Fax: 770-488-6000. E-mail address:(E.S. Ford)
    • ,
  • Wayne H Giles

      Affiliations

    • Division of Nutrition and Physical Activity and Division of Adult Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, Atlanta, GA, 30341 USA

Received 29 September 1998 ,Accepted 28 June 1999.

References 

  1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242–250
  2. Alexander RW. Inflammation and coronary artery disease. N Engl J Med. 1994;331:468–469
  3. Pepys MB. The acute phase response and C-reactive protein. In:  Weatherall DJ,  Ledingham JGG,  Warrell DA editor. Oxford Textbook of Medicine. New York, NY: Oxford University Press; 1996;p. 1527–1533
  4. Meade TW, North WR, Chakrabarti R, et al.  Haemostatic function and cardiovascular death (early results of a prospective study). Lancet. 1980;1:1050–1054
  5. Wilhelmsen L, Svärdsudd K, Korsan-Benjsten K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501–505
  6. Stone MC, Thorp JM. Plasma fibrinogen—a major coronary risk factor. J Royal Coll Gen Pract. 1985;35:565–569
  7. Meade TW, Mellows S, Brozovic M, et al.  Haemostatic function and ischaemic heart disease (principal results of the Northwick Park Heart Study). Lancet. 1986;2:533–537
  8. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA. 1987;258:1183–1186
  9. Yarnell JW, Baker IA, Sweetnam PM, et al.  Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation. 1991;83:836–844
  10. Eriksson H, Korsan-Bengtsen K, Welin L, et al.  21-year follow-up of CHD and total mortality among men born in 1913. In:  Ernst E,  Koemig W,  Lowe GDO,  Meade TW editor. Fibrinogen (a “New” Cardiovascular Risk Factor). Vienna, Austria: Blackwell; 1992;p. 115–119
  11. Heinrich J, Balleisen L, Schulte H, Assman G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk (results from the PROCAM study in healthy men). Arterioscler Thromb. 1994;14:54–59
  12. Freyburger G, Labrouche S, Sassoust G, Rouanet F, Javorschi S, Parrot F. Mild hyperhomocysteinemia and hemostatic factors in patients with arterial vascular diseases. Thromb Haemost. 1997;77:466–471
  13. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor (A meta-analysis and review of the literature). Ann Intern Med. 1993;118:956–963
  14. Kushner I, Broder ML, Karp D. Control of the acute phase response (serum C-reactive protein kinetics after acute myocardial infarction). J Clin Invest. 1978;61:235–242
  15. de Beer FC, Hind CR, Fox KM, Allan RM, Maseri A, Pepys MB. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J. 1982;47:239–243
  16. De Maat MPM, de Bart ACW, Hennis BC, et al.  Interindividual and intraindividual variability in plasm fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris. Arterioscler Thromb Vasc Biol. 1996;16:1156–1162
  17. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors (a population based cross sectional study). Br Med J. 1996;312:1061–1065
  18. Kuller LH, Tracy RP, Shaten J, Meilahn EN for the MRFIT Group . Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol. 1996;144:537–547
  19. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–979
  20. Tracy RP, Lemaitre RN, Psaty BM, et al.  Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Biol. 1997;17:1121–1127
  21. Liuzzo B, Biasucci LM, Gallimore JR, et al.  The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;331:417–424
  22. Thompson SG, Kienast J, Pyke SDM, et al.  Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635–641
  23. Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Circulation. 1997;96:4204–4210
  24. Oltrona L, Ardissino D, Merlini PA, Spinola A, Chiodo F, Pezzano A. C-reactive protein elevation and early outcome in patients with unstable angina pectoris. Am J Cardiol. 1997;80:1002–1006
  25. Centers for Disease Control and Prevention . Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988–94. Vital Health Stat 1(32). Bethesda, MD: National Center for Health Statistics; 1994;
  26. Centers for Disease Control and Prevention . The Third National Health and Nutrition Examination Survey (NHANES III 1988–94) Reference Manuals and Reports. (CD-ROM). Bethesda, MD: National Center for Health Statistics; 1996;
  27. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull WHO. 1962;27:645–658
  28. Rose GA, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med. 1977;31:42–48
  29. Campbell MJ, Elwood PC, Abbas S, et al.  Chest pain in women (a study of prevalence and mortality follow up in South Wales). J Epidemiol Comm Health. 1984;38:17–20
  30. Sorlie PD, Cooper L, Schreiner PJ, Rosamond W, Szklo M. Repeatability and validity of the rose questionnaire for angina pectoris in the Atherosclerosis Risk in Committee Study. J Clin Epidemiol. 1996;49:719–725
  31. Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S. The electrocardiograms in population studies (a classification system). Circulation. 1960;21:1160–1175
  32. Rautaharju PM, McInnes PJ, Warren JW, et al.  Methodology of ECG interpretation in the Dalhousie Program (NOVACODE ECG classification procedures for clinical trials and population surveys). Methods Inf Med. 1990;29:362–374
  33. Shah BV, Barnwell BG, Bieler GS. SUDAAN User's Manual, Version 7.5. Research Triangle Park, NC: Research Triangle Institute; 1997;
  34. Lowe GD, Wood DA, Douglas JT, et al.  Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina. Thromb Haemost. 1991;65:339–343
  35. Vaziri ND, Kennedy SC, Kennedy D, Gonzales E. Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris. Am J Med. 1992;93:651–657
  36. al-Nozha M, Gader AM, al-Momen AK, Noah MS, Jawaid M, Arafa M. Haemostatic variables in patients with unstable angina. Int J Cardiol. 1994;43:269–277
  37. Held C, Hjemdahl P, Rehnqvist N, et al.  Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study in Stockholm (APSIS). A comparison with healthy controls. J Int Med. 1997;241:59–69
  38. Lee AJ, Lowe GD, Woodward M, Tunstall-Pedoe H. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history (the Scottish Heart Health Study). Br Heart J. 1993;69:338–342
  39. Benchimol D, Dartigues JF, Benchimol H, et al.  Predictive value of hemostatic factors for sudden death in patients with stable angina pectoris. Am J Cardiol. 1995;76:241–244
  40. Becker RC, Cannon CP, Bovill EG, et al.  Prognostic values of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial). Am J Cardiol. 1996;78:142–147
  41. Cortellaro M, Boschetti C, Cofrancesco E, et al.  The PLAT Study (hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results). Arterioscler Thromb. 1992;12:1063–1070

PII: S0895-4356(99)00143-2

Journal of Clinical Epidemiology
Volume 53, Issue 1 , Pages 95-102 , January 2000

Article Tools